Bonum Therapeutics uses a novel, antibody-based mechanism to create regulated and targeted, highly active, and less toxic medicines, focusing on antibody-controlled cytokine-based therapeutics for cancer treatment
Bonum Therapeutics uses a novel, antibody-based mechanism to create regulated and targeted, highly active, and less toxic medicines, focusing on antibody-controlled cytokine-based therapeutics for cancer treatment.